Title | Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, V Chaluvadi S, Dustin ML, Hla T, Elemento O, Chipuk JE, Schwab SR |
Journal | Nature |
Volume | 546 |
Issue | 7656 |
Pagination | 158-161 |
Date Published | 2017 06 01 |
ISSN | 1476-4687 |
Keywords | Animals, Anion Transport Proteins, Cell Movement, Cell Survival, Endothelial Cells, Female, Lymph Nodes, Lymphoid Tissue, Lysophospholipids, Male, Mice, Mice, Transgenic, Mitochondria, Peyer's Patches, Receptors, Lysosphingolipid, Signal Transduction, Sphingosine, Spleen, T-Lymphocytes |
Abstract | Effective adaptive immune responses require a large repertoire of naive T cells that migrate throughout the body, rapidly identifying almost any foreign peptide. Because the production of T cells declines with age, naive T cells must be long-lived. However, it remains unclear how naive T cells survive for years while constantly travelling. The chemoattractant sphingosine 1-phosphate (S1P) guides T cell circulation among secondary lymphoid organs, including spleen, lymph nodes and Peyer's patches, where T cells search for antigens. The concentration of S1P is higher in circulatory fluids than in lymphoid organs, and the S1P receptor (S1PR) directs the exit of T cells from the spleen into blood, and from lymph nodes and Peyer's patches into lymph. Here we show that S1P is essential not only for the circulation of naive T cells, but also for their survival. Using transgenic mouse models, we demonstrate that lymphatic endothelial cells support the survival of T cells by secreting S1P via the transporter SPNS2, that this S1P signals through S1PR on T cells, and that the requirement for S1PR is independent of the established role of the receptor in guiding exit from lymph nodes. S1P signalling maintains the mitochondrial content of naive T cells, providing cells with the energy to continue their constant migration. The S1P signalling pathway is being targeted therapeutically to inhibit autoreactive T cell trafficking, and these findings suggest that it may be possible simultaneously to target autoreactive or malignant cell survival. |
DOI | 10.1038/nature22352 |
Alternate Journal | Nature |
PubMed ID | 28538737 |
PubMed Central ID | PMC5683179 |
Grant List | R01 AI123308 / AI / NIAID NIH HHS / United States R21 AI124129 / AI / NIAID NIH HHS / United States R01 AI085166 / AI / NIAID NIH HHS / United States T32 GM007308 / GM / NIGMS NIH HHS / United States R01 CA194547 / CA / NCI NIH HHS / United States R01 CA202025 / CA / NCI NIH HHS / United States P30 DK020541 / DK / NIDDK NIH HHS / United States R37 AI043542 / AI / NIAID NIH HHS / United States T32 AI100853 / AI / NIAID NIH HHS / United States R01 CA206005 / CA / NCI NIH HHS / United States P30 CA196521 / CA / NCI NIH HHS / United States R01 HL089934 / HL / NHLBI NIH HHS / United States |